Peptide Therapy
LQV Branded Vial
Cagrilintide
Peptide Therapy
Cagrilintide
From $349|
Provider Approved
Rx RequiredCagrilintide is a long-acting amylin analog that enhances satiety signaling. It works through a distinct mechanism from GLP-1 therapies, targeting the amylin pathway to help patients feel full sooner and reduce overall food intake.
Key Benefits
Enhanced satiety and reduced hunger between meals
Complementary mechanism to GLP-1 therapies
Improved post-meal blood sugar control
Reduced overall caloric intake
Potential for combination therapy with other weight management agents
1
Total$349.00
Medically directedShips nationwide
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.